Reuters logo
9 个月内
BRIEF-Exelixis announces Phase 1 trial results for Cabozantinib in combination with Nivolumab in advanced Genitourinary tumors
2016年10月7日 / 早上8点06分 / 9 个月内

BRIEF-Exelixis announces Phase 1 trial results for Cabozantinib in combination with Nivolumab in advanced Genitourinary tumors

1 分钟阅读

Oct 7 (Reuters) - Exelixis Inc :

* Says findings will be presented during a poster discussion session on October 9

* Exelixis announces Phase 1 trial results for Cabozantinib in combination with Nivolumab in advanced Genitourinary tumors Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below